On Monday, the U.S. Food and Drug Administration (FDA) issued warnings about the rare nerve syndrome to the Johnson & Johnson’s coronavirus vaccine can lead to an increased risk of a rare neurological condition known as Guillain–Barré syndrome. The Guillain–Barré syndrome […]